Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SMMT

Summit Therapeutics

$10.69

-0.0166 (-0.15%)

07:06
11/20/17
11/20
07:06
11/20/17
07:06
Hot Stocks
Summit Therapeutics completes initial 24 weeks of dosing in PhaseOut DMD trial »

Summit Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

Over a month ago
SMMT

Summit Therapeutics

$12.39

-0.32 (-2.52%)

04:55
10/13/17
10/13
04:55
10/13/17
04:55
Conference/Events
Summit Therapeutics management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

SMMT

Summit Therapeutics

04:55
10/12/17
10/12
04:55
10/12/17
04:55
Conference/Events
Summit Therapeutics management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 13

    Oct

SMMT

Summit Therapeutics

$12.71

0.21 (1.68%)

08:25
10/11/17
10/11
08:25
10/11/17
08:25
Conference/Events
Summit Therapeutics to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

  • 12

    Oct

  • 13

    Oct

SMMT

Summit Therapeutics

$12.71

0.21 (1.68%)

04:55
10/11/17
10/11
04:55
10/11/17
04:55
Conference/Events
Summit Therapeutics to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

  • 12

    Oct

  • 13

    Oct

SMMT

Summit Therapeutics

$12.50

-0.26 (-2.04%)

14:47
10/10/17
10/10
14:47
10/10/17
14:47
Conference/Events
Summit Therapeutics to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 13

    Oct

SMMT

Summit Therapeutics

$12.76

-0.03 (-0.23%)

09:50
10/09/17
10/09
09:50
10/09/17
09:50
Conference/Events
Summit Therapeutics management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 13

    Oct

SMMT

Summit Therapeutics

$15.25

-0.4801 (-3.05%)

06:27
09/14/17
09/14
06:27
09/14/17
06:27
Syndicate
Summit Therapeutics 1.459M share Spot Secondary priced at $12.00 »

Canaccord and JMP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

SMMT

Summit Therapeutics

$15.25

-0.4801 (-3.05%)

16:36
09/13/17
09/13
16:36
09/13/17
16:36
Syndicate
Summit Therapeutics files to sell $15M of American Depositary Shares »

Each ADS will represent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
SMMT

Summit Therapeutics

$13.92

-0.06 (-0.43%)

04:55
08/02/17
08/02
04:55
08/02/17
04:55
Conference/Events
Summit Therapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.